| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |